title: Response to the letter from Gozzetti et al. entitled: "Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders".
authors.affiliation: Hematology, Derriford Hospital , Plymouth , UK.
authors.forename: Simon
authors.initials: S
authors.lastname: Rule
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*